NOTE F5 Results from portfolio management and reassessments, legacy remediation and major litigations
- Index
- 1 NOTE F1 Segment information
- 2 NOTE F2 Consolidated income statement by nature
- 3 NOTE F3 Revenue from non-core activities
- 4 NOTE F4 Other operating gains and losses
- 5 NOTE F5 Results from portfolio management and reassessments, legacy remediation and major litigations
- 6 NOTE F6 Net financial charges
- 7 NOTE F7 Income taxes
- 8 NOTE F8 Discontinued operations
- 9 NOTE F9 Profit for the year
- 10 NOTE F10 Earnings per share
Accounting policy
Results from portfolio management and reassessments include:
- gains and losses on the sale of subsidiaries, joint operations, joint ventures, and associates that do not qualify as discontinued operations,
- acquisition costs of new businesses,
- gains and losses on the sale of real estate not directly linked to an operating activity,
- restructuring charges driven by portfolio management and reassessment, including impairment losses resulting from the shutdown of an activity or a plant, and
- impairment losses resulting from testing of CGUs.
Results from legacy remediation and major litigations include:
- the remediation costs not generated by on-going production facilities (shut-down of sites, discontinued productions, previous years’ pollution) and
- the impact of significant litigations.
Results from portfolio management and reassessments
In € million |
2017 |
2016 |
||
Restructuring costs and impairment |
(143) |
(239) |
||
M&A costs and gains and losses on disposals |
(45) |
82 |
||
Results from portfolio management and reassessments |
(188) |
(157) |
Results from legacy remediation and major litigations
In € million |
2017 |
2016 |
||
Major litigations |
(16) |
(12) |
||
Remediation costs and other costs related to non-ongoing activities |
(69) |
(42) |
||
Results from legacy remediation and major litigations |
(84) |
(54) |
In 2017, these items relate primarily to:
- Restructuring costs and impairment relating to:
- the closure of sites in China and Korea (€(13) million),
- the closure of sites of the Soda Ash business (€(23) million),
- Impairment with respect to Polyamides retained assets (€(91) million),
- M&A costs and gains and losses on disposals:
- the deconsolidation of the Venezuelan entity (€(72) million, of which €(60) million for CTA recycling),
- the gain on the Cross Linkable Compound business divestment (€43 million),
- the loss on the disposal of Dacarto Benvic (€(13) million).
In 2016, these items related primarily to:
- Restructuring costs and impairment relating to:
- the mothballing of the Soda Ash plant in Egypt (€(112) million),
- the divestment decision of the US torrefied biomass electricity generation project (€(39) million),
- the resizing of Solvay’s shared services due to the changes in the Group’s portfolio (€(40) million),
- the impact of adverse market conditions on the Brazilian electricity cogeneration assets (€(28) million),
- M&A costs and gains and losses on disposals:
- gain on Inovyn divestment (€71 million),
- loss on the disposal of a peroxide business in Bussi (Italy) (€(13) million),
- gain following additional reversal of the holdback included in the Chemlogics purchase price and subject to performance conditions not reached in 2016 (€49 million), and
- M&A acquisition costs for €(25) million.